SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
SEC Accession No. 0001437749-22-002588
Filing Date
2022-02-07
Accepted
2022-02-07 13:26:53
Documents
1
Group Members
FRANK G. PILKIEWICZ REVOCABLE TRUST DTD 10-17-2001MICHAEL B. DEGIDIO

Document Format Files

Seq Description Document Type Size
1 SCHEDULE 13G/A caro20220202_sc13ga.htm SC 13G/A 102519
  Complete submission text file 0001437749-22-002588.txt   104070
Mailing Address 9920 PACIFIC HEIGHTS BLVD, SUITE 150 SAN DIEGO CA 92121
Business Address 9920 PACIFIC HEIGHTS BLVD, SUITE 150 SAN DIEGO CA 92121 (858) 350-4364
Kintara Therapeutics, Inc. (Subject) CIK: 0001498382 (see all company filings)

IRS No.: 990360497 | State of Incorp.: NV | Fiscal Year End: 0630
Type: SC 13G/A | Act: 34 | File No.: 005-87181 | Film No.: 22596641
SIC: 2834 Pharmaceutical Preparations

Mailing Address 3 DAVENPORT DRIVE PRINCETON JUNCTION NJ 08550
Business Address
Pilkiewicz Carolyn (Filed by) CIK: 0001830372 (see all company filings)

Type: SC 13G/A